Sector Pharmaceuticals & Biotech. - Latest news, views and updates

SECTOR | 18 Mar 2025

Essential Medicines List 2022 price cuts save patients Rs 3,788 cr annually

Business Standard

Under the AMRIT initiative, medicines for cancer, cardiovascular diseases, and surgical implants are available at up to 50 per cent discounts in selected hospital pharmacies

Pharmaceuticals & Biotech.

SECTOR | 13 Mar 2025

Medical device industry lists 12 products seeing a surge in imports

Business Line

Concerned that tariff wars could exacerbate situation

Pharmaceuticals & Biotech.

SECTOR | 28 Feb 2025

Jan Aushadhi Sales Likely To Cross Rs 2,000-Crore Mark This Fiscal: Pharma And Medical Devices Bureau CEO

NDTV Profit

PMBI, under the Department of Pharmaceuticals, implements Jan Aushadhi outlets under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme.

Pharmaceuticals & Biotech.

SECTOR | 27 Feb 2025

Trump Ends Thousands Of USAID-Funded Programs In South Africa

NDTV Profit

The United States Agency for International Development letters, earlier published by local news service Bhekisisa, were also sent to groups funded by the President's Emergency Plan for AIDS Relief.

Pharmaceuticals & Biotech.

SECTOR | 25 Feb 2025

Regulatory Standards Should Be Strengthened To Ensure Quality Medicines: Health Secretary

NDTV Profit

The meeting comes in the wake of the Drugs Controller General of India prohibiting the production and export of all combinations of pain relief medicines tapentadol and carisoprodol.

Pharmaceuticals & Biotech.

SECTOR | 25 Feb 2025

Mystery illness kills over 50 in Congo, patients die within 48 hours: WHO raises alarm

Economic Times

An unknown illness has killed over 50 people in northwestern Congo. The majority of the cases have symptoms within 48 hours. The outbreak started on January 21, and 419 cases have been recorded so far. The World Health Organisation is investigating. Samples tested negative for Ebola and other common hemorrhagic fever diseases. Some tested positive for malaria.

Pharmaceuticals & Biotech.

SECTOR | 24 Feb 2025

Pfizer Share Price Jumps After Pact With Mylan Pharmaceuticals

NDTV Profit

Pfizer will conduct marketing and sales of Ativan and Pacitane, two brands owned by Mylan Pharmaceuticals.

Pfizer shares gain 9% after board approves agreement with Mylan Pharma

Business Standard | 24 Feb 2025

Pharmaceuticals & Biotech.

SECTOR | 23 Feb 2025

SC to hear plea over shortage of drugs for treating HIV patients on Monday

Business Standard

The Supreme Court is scheduled to hear on Monday a plea concerning alleged shortage of anti-retroviral therapy drugs for treating HIV patients in the country. As per the cause list of February 24 uploaded on the apex court website, a bench comprising Justices Abhay S Oka and Ujjal Bhuyan is slated to hear the petition filed in 2022 by NGO 'Network of People Living with HIV/AIDS' and others. The Centre had in July last year apprised the apex court that the government was ensuring availability of free, life-long anti-retroviral (ARV) drugs for all people living with HIV through anti-retroviral therapy centres under the National AIDS Control Programme. It had said as on date, there was adequate stock of all ARV drugs nationally under the programme. The counsel appearing for the petitioners had said in view of the developments which had taken place since the filing of the petition, presently there was no shortage of ART drugs. However, the counsel had flagged certain difficulties in .

Pharmaceuticals & Biotech.

SECTOR | 21 Feb 2025

Pfizer Board Approves Marketing, Supply Pact With Mylan For Two Brands

NDTV Profit

Ativan is used for the treatment of anxiety disorders while Pacitane is indicated as adjunctive treatment of all forms of Parkinsonism.

Pharmaceuticals & Biotech.

SECTOR | 21 Feb 2025

Pharma sector can deliver 100 new drugs by 2047: Zydus chairman

Business Standard

Indian pharma industry is capable of delivering 100 new drugs by 2047 for global markets backed by enhanced research and development efforts, Zydus Lifesciences Chairman Pankaj R Patel said on Friday. Speaking at an event here, he stressed the need for innovation, capability building, and a focus on societal benefit. "I believe India can deliver 100 new chemical entities or new drugs to the world by 2047 and off course, it will require effort," Patel said while speaking at the SOUL leadership conclave 2025. He termed it a myth that drug discovery requires a billion dollars while emphasising that it is possible with the right approach. Patel also asserted that the people working in an organisation are the most valuable resource and pitched for an environment where people love to work. He also emphasised the evolving nature of leadership, highlighting the importance of humility, vision, and a global perspective. Patel also shared experiences, including the Prime Minister's proactiv